{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:48:26Z","timestamp":1791143306885,"version":"4.1.0"},"reference-count":16,"publisher":"BMJ","issue":"Suppl 4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Sex Transm Infect"],"accepted":{"date-parts":[[2013,8,18]]},"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:p>Antimicrobial resistance in<jats:italic>Neisseria gonorrhoeae<\/jats:italic>is monitored in the European Union\/European Economic Area through the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP) coordinated by the European Centre for Disease Prevention and Control. Euro-GASP includes a sentinel surveillance programme which aims to detect in a timely manner changes in resistance patterns and inform treatment guidelines. The programme aims to test a representative number of isolates from each European Union\/European Economic Area member state per year for a range of therapeutically relevant antimicrobials through a biannual hybrid centralised\/decentralised system. Testing is supported by an External Quality Assurance programme and a laboratory training programme. Participation in the programme has increased to 21 countries in 2012. Euro-GASP has been able to detect the rapid spread of isolates with decreased susceptibility to cefixime across Europe in 2010 and 2011. Results from the programme have informed changes in European treatment guidelines for gonorrhoea and led to the development of the \u2018Response plan to control and manage the threat of multidrug resistant gonorrhoea in Europe\u2019. Future challenges for Euro-GASP include supporting countries to participate in Euro-GASP through decentralised testing, improving timeliness and epidemiological data quality, and increasing participation from Eastern Europe.<\/jats:p>","DOI":"10.1136\/sextrans-2013-051117","type":"journal-article","created":{"date-parts":[[2013,11,15]],"date-time":"2013-11-15T14:33:46Z","timestamp":1384526026000},"page":"iv16-iv18","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":41,"title":["The European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP)\u2014a sentinel approach in the European Union (EU)\/European Economic Area (EEA)"],"prefix":"10.1136","volume":"89","author":[{"given":"Gianfranco","family":"Spiteri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Unemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steen","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Ison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marita","family":"van de Laar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2013,11,15]]},"reference":[{"key":"2024051410180286000_89.Suppl_4.iv16.1","unstructured":"European Centre for Disease Prevention and Control. Sexually transmitted infections in Europe 2011. 2013. http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/sexually-transmitted-infections-Europe-2011.pdf (accessed 5 Sep 2013)."},{"key":"2024051410180286000_89.Suppl_4.iv16.2","doi-asserted-by":"crossref","unstructured":"Unemo M Golparian D Potocnik M . Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September. Euro Surveill 2012;17:2\u20135.","DOI":"10.2807\/ese.17.25.20200-en"},{"key":"2024051410180286000_89.Suppl_4.iv16.3","doi-asserted-by":"crossref","unstructured":"Unemo M Golparian D Nicholas R . High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother 2011. 2012;56:1273\u201380.","DOI":"10.1128\/AAC.05760-11"},{"key":"2024051410180286000_89.Suppl_4.iv16.4","doi-asserted-by":"crossref","unstructured":"Ison CA Hussey J Sankar KN . Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. Euro Surveill 2011;16 :7\u201310.","DOI":"10.2807\/ese.16.14.19833-en"},{"key":"2024051410180286000_89.Suppl_4.iv16.5","doi-asserted-by":"crossref","unstructured":"Unemo M Golparian D Stary A . First Neisseria Gonorrhoeae strain with resistance to Cefixime causing Gonorrhoea treatment failure in Austria. Eurosurveillance 2011;16:9\u201311.","DOI":"10.2807\/ese.16.43.19998-en"},{"key":"2024051410180286000_89.Suppl_4.iv16.6","doi-asserted-by":"crossref","unstructured":"Unemo M Golparian D Hestner A . Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010. Euro Surveill 2011;16:5\u20137. doi:19792 [pii][published Online First: Epub Date].","DOI":"10.2807\/ese.16.06.19792-en"},{"key":"2024051410180286000_89.Suppl_4.iv16.7","unstructured":"European Centre for Disease Prevention and Control. Gonococcal antimicrobial susceptibility surveillance in Europe\u20142010. 2012. http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/1206-Gonococcal-AMR.pdf (accessed 18 Apr 2013)."},{"key":"2024051410180286000_89.Suppl_4.iv16.8","unstructured":"European Centre for Disease Prevention and Control. Gonococcal antimicrobial susceptibility surveillance in Europe 2011. 2013. http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/gonococcal-antimicrobial-susceptibility-surveillance-27-mar-2013.pdf (accessed 18 Apr 2013)."},{"key":"2024051410180286000_89.Suppl_4.iv16.9","unstructured":"European Centre for Disease Prevention and Control. Gonococcal antimicrobial susceptibility surveillance in Europe 2009. 2011. http:\/\/ecdc.europa.eu\/en\/publications\/publications\/1101_sur_gonococcal_susceptibility_2009.pdf (accessed 18 Apr 2013)."},{"key":"2024051410180286000_89.Suppl_4.iv16.10","doi-asserted-by":"crossref","unstructured":"Chisholm SA Unemo M Quaye N . Molecular epidemiological typing within the European Gonococcal Antimicrobial Resistance Surveillance Programme reveals predominance of a multidrug-resistant clone. Euro Surveill 2013;18:14\u201323.","DOI":"10.2807\/ese.18.03.20358-en"},{"key":"2024051410180286000_89.Suppl_4.iv16.11","doi-asserted-by":"crossref","unstructured":"Cole MJ Unemo M Hoffmann S . The European gonococcal antimicrobial surveillance programme, 2009. Euro Surveill 2011;16:12\u201317. doi:19995 [pii][published Online First: Epub Date].","DOI":"10.2807\/ese.16.42.19995-en"},{"key":"2024051410180286000_89.Suppl_4.iv16.12","doi-asserted-by":"crossref","unstructured":"Bignell C Unemo M , European STI Guidelines Editorial Board. 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults. 2012. http:\/\/www.iusti.org\/regions\/europe\/pdf\/2012\/Gonorrhoea_2012.pdf (accessed 18 Apr 2013).","DOI":"10.2807\/ese.17.47.20323-en"},{"key":"2024051410180286000_89.Suppl_4.iv16.13","doi-asserted-by":"crossref","unstructured":"Unemo M , European STI Guidelines Editorial Board. The 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults recommends dual antimicrobial therapy. Euro Surveill 2012;17.","DOI":"10.2807\/ese.17.47.20323-en"},{"key":"2024051410180286000_89.Suppl_4.iv16.14","unstructured":"European Commission. Commission Decision 2002\/253\/EC of 19 March 2002 laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119\/98\/EC of the European Parliament and of the Council. J Eur Union 2002. http:\/\/eur-lex.europa.eu\/LexUriServ\/LexUriServ.do?uri=OJ:L:2002:086:0044:0062:EN:PDF (accessed 18 Apr 2013)."},{"key":"2024051410180286000_89.Suppl_4.iv16.15","unstructured":"European Centre for Disease Prevention and Control. Molecular typing of Neisseria gonorrhoeae . 2012. http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/201211109-Molecular-typing-gonorrhea.pdf (accessed 18 Apr 2013)."},{"key":"2024051410180286000_89.Suppl_4.iv16.16","unstructured":"European Centre for Disease Prevention and Control. Response plan to control and manage the threat of multidrug-resistant gonorrhoea in Europe. 2012. http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/1206-ECDC-MDR-gonorrhoea-response-plan.pdf (accessed 18 Apr 2013)."}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/sextrans-2013-051117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T17:18:44Z","timestamp":1715707124000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2013-051117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,15]]},"references-count":16,"journal-issue":{"issue":"Suppl 4","published-online":{"date-parts":[[2013,11,15]]},"published-print":{"date-parts":[[2013,12]]}},"alternative-id":["10.1136\/sextrans-2013-051117"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2013-051117","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"value":"1368-4973","type":"print"},{"value":"1472-3263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,15]]}}}